E-LIB Suche - Ergebnisse für: Jimenez de la Paz, Delvys

1

Revisión a través de un caso clínico de lesiones pretibiale:

Jimenez de la Paz, Delvys ; Herranz Martinez, Cristina
Atención Primaria. 51 (2019) 3 - p. 189-190 , 2019

Link: https://doi.org/10.1016/..

2

Assessment of a New ROS1 Immunohistochemistry Clone (SP384)..:

Conde, Esther ; Hernández, Susana ; Martinez, Rebeca...
Instituto de Salud Carlos III PI14-01176. , 2019

Link: https://ddd.uab.cat/reco..

3

Assessment of a New ROS1 Immunohistochemistry Clone (SP384)..:

Conde, E. (Esther) ; Hernández, S. (Susana) ; Martínez-Turrillas, R. (Rebeca)...
https://hdl.handle.net/10171/62012. , 2019

Link: https://hdl.handle.net/1..

4

Assessment of a New ROS1 Immunohistochemistry Clone (SP384)..:

Conde, Esther ; Hernandez, Susana ; Martinez, Rebeca...
http://hdl.handle.net/10668/14313. , 2019

Link: http://hdl.handle.net/10..

5

Phase II study of afatinib plus pembrolizumab in patients w..:

Levy, Benjamin ; Barlesi, Fabrice ; Paz-Ares, Luis...
Lung Cancer. 166 (2022) - p. 107-113 , 2022

Link: https://doi.org/10.1016/..

6

Are there any significant variations in the clinical or his..:

Spanish Lymphoma Oncology Group ; Provencio, Mariano ; Sabín, Pilar...
Clinical and Translational Oncology. 14 (2012) 5 - p. 386-390 , 2012

Link: https://doi.org/10.1007/..

7

Afatinib With Pembrolizumab for Treatment of Patients With ..:

Levy, Benjamin ; Paz-Ares, Luis ; Bennouna, Jaafar...
Clinical Lung Cancer. 20 (2019) 3 - p. e407-e412 , 2019

Link: https://doi.org/10.1016/..

8

MA07.05 EUCROSS: A European Phase II Trial of Crizotinib in..:

Michels, Sebastian ; Gardizi, Masyar ; Schmalz, Petra...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S379-S380 , 2017

Link: https://doi.org/10.1016/..

9

Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With P..:

Gadgeel, Shirish M. ; Rodríguez-Abreu, Delvys ; Halmos, Balazs...
Journal of Thoracic Oncology. 19 (2024) 8 - p. 1228-1241 , 2024

Link: https://doi.org/10.1016/..

10

CD8+ NKs as a potential biomarker of complete response and ..:

Hontecillas-Prieto, Lourdes ; García-Domínguez, Daniel J. ; Palazón-Carrión, Natalia...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

11

Associations of Tissue Tumor Mutational Burden and Mutation..:

Garassino, Marina C. ; Gadgeel, Shirish ; Novello, Silvia...
JTO Clinical and Research Reports. 4 (2023) 1 - p. 100431 , 2023

Link: https://doi.org/10.1016/..

12

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Dif..:

Palazón-Carrión, Natalia ; Martín García-Sancho, Alejandro ; Nogales-Fernández, Esteban...
Clinical Cancer Research. 28 (2022) 17 - p. 3658-3668 , 2022

Link: https://doi.org/10.1158/..

13

Outcomes With Pembrolizumab Plus Platinum-Based Chemotherap..:

Powell, Steven F. ; Rodríguez-Abreu, Delvys ; Langer, Corey J....
Journal of Thoracic Oncology. 16 (2021) 11 - p. 1883-1892 , 2021

Link: https://doi.org/10.1016/..

14

Circulating myeloid-derived suppressor cells and regulatory..:

Jiménez-Cortegana, Carlos ; Palazón-Carrión, Natalia ; Martin Garcia-Sancho, Alejandro...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002323 , 2021

Link: https://doi.org/10.1136/..

15

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatm..:

Majem, Margarita ; Cobo, Manuel ; Isla, Dolores...
Journal of Clinical Medicine. 10 (2021) 7 - p. 1365 , 2021

Link: https://doi.org/10.3390/..